“The Autologous CaTeVac Dendritic Cell Vaccine in Patients with Melanoma: Final Results of the DENDRON-01 Study”, Вопр. онкол., vol. 71, no. 4, p. OF-2437, Sep. 2025, doi: 10.37469/0507-3758-2025-71-4-OF-2437.